Skip to main content
Top

Breast Cancer

Issue 1/1997

Content (10 Articles)

Original Article

Analysis of Cdc2 and Cyclin D1 expression in breast cancer by immunoblotting

Tomohiko Ohta, Mamoru Fukuda, Kei Arima, Hisanori Kawamoto, Rintaro Hashizume, Toshihiro Arimura, Susumu Yamaguchi

Original Article

Serum soluble interleukin 2 receptor levels in patients with breast cancer

Saburo Murakami, Rennzo Hirayama, Akira Satomi, Katsuhiko Okubo, Moriyoki Matsuki, Hideto Sakata, Yoshitaka Tsuji

Case Report

Angiosarcoma of the breast: Report of a case and autopsy findings

Yoshihiro Kagawa, Toshiaki Saeki, Wataru Takiyama, Shigemitsu Takashima, Koichi Mandai

Case Report

A case of microangiopathic hemolytic anemia associated with breast cancer: Improvement with chemoendocrine therapy

Masashi Narita, Kazuyasu Nakao, Nobuo Ogino, Takashi Emoto, Masaaki Nakahara, Takeyoshi Yumiba, Masahiko Tsujimoto

Case Report

Ectopic breast cancer: Two case reports and review of the Japanese literature

Futoshi Kawahara, Masakuni Noguchi, Noboru Yamamichi, Fumio Konishi, Ryo Yagasaki, Masahide Minami, Mitsuharu Earashi, Kazuo Kinoshita, Takao Taniya, Itsuo Miyazaki

Case Report

Accessory breast cancer: A case report of carcinoma originating from aberrant breast tissue in the axillar region

Takashi Azuma, Katsuhiko Yamamoto, Tsunehiro Kobayashi, Hiroshige Nakano

Case Report

A case of dermatofibrosarcoma protuberans in the skin over the breast

Tohru Sakuragi, Kumi Fujiwara, Sadako Akashi-Tanaka, Hitoshi Tsuda, Takashi Fukutomi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine